Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-033127
Filing Date
2026-03-23
Accepted
2026-03-23 19:13:53
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-72705.html 3  
1 PRIMARY DOCUMENT marketforms-72705.xml 3 6660
2 POA DOCUMENT poa.htm EX-24 5997
  Complete submission text file 0001213900-26-033127.txt   14264
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Issuer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ASCENTAGE PHARMA GROUP INC. 700 KING FARM BLVD., SUITE 510 ROCKVILLE MD 20850
Business Address
Wang Shaomeng (Reporting) CIK: 0002122971 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42484 | Film No.: 26783811